Diagnosis of axillary lymph node metastases in patients with breast cancer

Breast Cancer Research and Treatment

Volumn 40, Issue 3, 1996, Pages 283-293

  Noguchi, Masakuni ^a,b   Katev, Nikolay ^c   Miyazaki, Itsuo ^a  

^a KANAZAWA UNIVERSITY   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c NONE

Author keywords

Axillary lymph node metastases; Breast cancer; Diagnosis

Indexed keywords

BIOLOGICAL MARKER;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; CYTOLOGY; DIAGNOSTIC IMAGING; DIAGNOSTIC VALUE; ECHOGRAPHY; FEMALE; HISTOLOGY; HUMAN; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAMMOGRAPHY; MORBIDITY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AXILLA; BREAST NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS;

EID: 0029814570     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01806817     Document Type: Article

References (97)

1. Fisher B, Redmond C, Fisher ER, Bauer M, Wolmark N, Wickerham L, Deutsch M, Montague E, Margolese R, Foster R: Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation. N Engl J Med 312: 674-681, 1985
2. Lythgoe JP, Palmer MK: Manchester regional breast study - 5 and 10 years results. Br J Surg 69: 693-696, 1982
3. Cancer Research Campaign Work Party: Cancer Research Campaign (King's/Cambridge) trial for early breast cancer. Lancet 2: 55-60, 1980
4. Hayward JL: The Guy's trial of treatment of 'early breast cancer'. World J Surg 1: 314-316, 1977
5. Cabanes PA, Salmon RJ, Vilcoq JR, Durand JC, Fourquet A, Gautier C, Asselain B: Value of axillary dissection in addition to lumpectomy and radiotherapy in early breast cancer. Lancet 339: 1245-1248, 1992
6. Kinne DW: Surgical management of stage I and stage II breast cancer. Cancer 66: 1373-1377, 1990
7. Kinne DW: Controversies in primary breast cancer management. Am J Surg 166: 502-508, 1993
8. Noguchi M, Kinne DW, Miyazaki I: Controversies in the surgical management of operable breast cancer. Breast Cancer 1: 79-88, 1994
9. Petrek J, Blackwood M: Axillary dissection: current practice and technique. Curr Probl Surg 32: 266-323, 1995
10. Harris JR, Osteen RT: Patients with early breast cancer benefit from axillary treatment. Breast Cancer Res Treat 5: 17-21, 1985
11. Hellman S, Harris JR: The appropriate breast cancer paradigm. Cancer Res 47: 339-342, 1987
12. Senofsky GM, Moffat FL Jr, Davis K, Masri MM, Clark KC, Robinson DS, Sabates B, Ketcham AS: Total axillary lymphadenopathy in the management of breast cancer. Arch Surg 126: 1336-1342, 1991
13. Moffat FL Jr, Senofsky GM, Davis K, Clark KC, Robinson DS, Ketcham AS: Axillary node dissection for early breast cancer: some is good, but all is better. J Surg Oncol 51: 8-13, 1992
14. Fentiman IS, Mansel RE: The axilla: not a no-go zone. Lancet 337: 221-223, 1991
15. Gaglia P, Bussone R, Caldarola B, Lai M, Jayme A, Caldarola L: The correlation between the spread of metastases by level in the axillary nodes and disease-free survival in breast cancer. A multifactorial analysis. Eur J Cancer Clin Oncol 23: 849-854, 1987
16. Lee YT, Chan LS: Surgical treatment of carcinoma of the breast: II. Prognostic factors influencing relapse rate. J Surg Oncol 25: 102-108, 1984
17. Fisher B, Bauer M, Wickerham DL, Redmond CK, Fisher ER, Cruz AB, Foster R, Gardner B, Lerner H, Margolese R, Poisson R, Shibata H, Volk H, and other NSABP investigators: Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update. Cancer 52: 1551-1557, 1983
18. Cascinelli N, Greco M, Bufalino R, Clemente C, Galluzo D, Donne VD, Lellis RD, Sacchini V, Veronesi U: Prognosis of breast cancer with axillary node metastases after surgical treatment only. Eur J Cancer Clin Oncol 23: 795-799, 1987
19. Noguchi M, Taniya T, de Aretxabala X, Kumaki T, Tajiri K, Miyazaki I, Mura T: The significance of regional lymph node dissection in the surgical management of breast cancer. Jpn J Surg 19: 21-28, 1989
20. Bismar B, Ljungdahl I: Postoperative lymphedema after treatment of breast cancer. Act Chir Scand 149: 687-691, 1963
21. Kissin MW, Querci della Rovere G, Easton D, Westbury G: Risk of lymphoedema following the treatment of breast cancer. Br J Surg 73: 580-585, 1986
22. Marzeron JJ, Otmezguine Y, Huart J, Pierquin B: Conservative treatment of breast cancer: results of management of axillary lymph node area in 3353 patients. Lancet: 1: 1387, 1985
23. Pamilo M, Soiva M, Lavast EM: Real-time ultrasound, axillary mammography, and clinical examination in the detection of axillary lymph node metastases in breast cancer patients. J Ultrasound Med 8: 115-120, 1989
24. Noguchi M, Ohta N, Thomas M, Kitagawa H, Earashi M, Miyazaki I, Mizukami Y: Clinical and biological prediction of axillary and internal mammary lymph node metastases in breast cancer. Surg Oncol 2: 51-58, 1993
25. March DE, Wechsler RJ, Kurtz AB, Rosenberg AL, Needleman L: CT-pathologic correlation of axillary lymph nodes in breast carcinoma. J Comput Assist Tomogr 15: 440-444, 1991
26. Wallace IWJ, Champion HR: Axillary nodes in breast cancer. Lancet i: 217-218, 1972
27. Sacre RA: Clinical evaluation of axillary lymph nodes compared to surgical and pathological findings. Eur J Surg Oncol 12: 169-173, 1986
28. Fisher B, Wolmark N, Bauer M, Redmond C, Gebhardt M: The accuracy of clinical nodal staging and of limited axillary dissection as a determinant of histologic nodal status in carcinoma of the breast. Surg Gynec Obstet 152: 765-772, 1981
29. Noguchi M, Thomas M, Kitagawa H, Kinoshita K, Ohta N, Nagamori M, Miyazaki I: Further analysis of predictive value of Helix pomatia lectin binding to primary breast cancer for axillary and internal mammary lymph node metastases. Br J Cancer 67: 1368-1371, 1993
30. Sacre R: Modern thoughts on lymph nodes in breast cancer. Semin Surg Oncol 5: 118-125, 1989
31. Coopmans de Yoldi GF, Andreoli C, Costa A, Nessi R, Gilardoni L, Rasponi A: Lack of efficacy of xeroradiography to preoperatively detect axillary lymph node metastases in breast cancer. Breast Cancer Res Treat 3: 373-376, 1983
32. Bruneton JN, Caramella E, Aubanel D, Manzino JJ, Picard JL: Axillary lymph node metastases in breast cancer: preoperative detection with US. Radiology 158: 325-326, 1986
33. Mustonen P, Farin P, Kosunen O: Ultrasonographic detection of metastatic axillary lymph nodes in breast cancer. Ann Chir Gynaecol 79: 15-18, 1990
34. Tate JJT, Lewis V, Archer T, Guyer PG, Royle GT, Taylor I: Ultrasound detection of axillary lymph node metastases in breast cancer. Eur J Surg Oncol 15: 139-141, 1989
35. McLean RG, Ege GN: Prognostic value of axillary lymphoscintigraphy in breast carcinoma patients. J Nucl Med 27: 1116-1124, 1986
36. Christensen B, Blichert-Toft M, Siemssen OJ, Nielsen SL: Reliability of axillary lymph node scintiphotography in suspected carcinoma of the breast. Br J Surg 67: 667-668, 1980
37. Fossel ER, Brodsky G, Delayre JL, Wilson RE: Nuclear magnetic resonance for the differentiation of benign and malignant breast tissues and axillary lymph nodes. Ann Surg 198: 541-545, 1983
38. Kaiser WA, Zeitler E: MR imaging of the breast: fast imaging sequences with and without Gd-DTPA, preliminary observation. Radiology 170: 681-686, 1989
39. Harms SE, Falig DP, Hesley KL, Meiches MD, Jensen RA, Evans WP, Savino DA, Wells RV: MR imaging of the breat with rotating delivery of excitation off resonance: clinical experience with pathologic correlation. Radiology 187: 493-501, 1993
40. Ashikari R, Hajdu SI, Robinson GF: Intraductal carcinoma of the breast (1960-1969). Cancer 28: 1182-1187, 1971
41. Silverstein MJ, Rosser RJ, Gierson ED, Waisman JR, Gamagami P, Hoffman RS, Fingerhut AG, Lewinsky BS, Colburn W, Handel N: Axillary lymph node dissection for intraductal breast carcinoma - Is it indicated? Cancer 59: 1819-1824, 1987
42. Lagios MD, Westdahl PR, Margolin FR, Rose MR: Duct carcinoma in situ. Relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 50: 1309-1314, 1982
43. Carter D, Smith RL: Carcinoma in situ of the breast. Cancer 40: 1189-1193, 1977
44. Noguchi M, Minami M, Earashi M, Taniya T, Miyazaki I, Mizukami Y, Nonomura A: Intraoperative assessment of axillary lymph node metastases in operable breast cancer. Breast Cancer Res Treat (in press)
45. Carter CL, Allen C, Henson DE: Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63: 181-187, 1989
46. Rosen PP, Groshen S: Factors influencing survival and prognosis in early breast carcinoma (TINOMO-TINIMO). Surg Clin North Am 70: 937-962, 1990
47. Say CC, Donegan WL: Invasive carcinoma of the breast: prognostic significance of tumor size and involved axillary lymph nodes. Cancer 34: 468-471, 1974
48. Kemoto T, Vana J, Natarajan N, Bedwani R, Mettlin C: Observations on short-term and long-term surveys of breast cancer by the American College of Surgeons. I. Significance of the number of axillary nodes, and II. Estrogen receptor assay in the U.S. in 1977. Int Adv Surg Oncol 4: 209-239, 1981
49. Ranaboldo CJ, Mitchel A, Royle GT, Theaker GM, Taylor I: Axillary nodal status in women with screen-detected breast cancer. Eur J Surg Oncol 19: 130-133, 1993
50. Ciatto S, Rosselli Del Turco M, Bonardi R, Cataliotti L, Distante V, Cardona G, Bianchi S: Non-palpable lesions of the breast detected by mammography - review of 1182 consecutive histologically confirmed cases. Eur J Cancer 30: 40-41, 1994
51. Seidman JD, Schnaper LA, Aisner S: Relationship of the size of the invasive component of the primary breast carcinoma to axillary lymph node metastases. Cancer 75: 65-71, 1995
52. Chadha M, Chabon AB, Friedmann P, Vikram B: Predictors of axillary lymph node metastases in patients with T1 breast cancer. Cancer 73: 350-353, 1994
53. Unzeitig GW, Frankl G, Ackerman M, O'Connell TX: Analysis of the prognosis of minimal and occult breast cancers. Arch Surg 118: 1403-1404, 1983.
54. Wong JH, Kopald KH, Morton DL: The impact of microinvasion on axillary node metastases and survival in patients with intraductal breast cancer. Arch Surg 125: 1298-1302, 1990
55. Reger V, Beito G, Jolly PC: Factors affecting the incidence of lymph node metastases in small cancers of the breast. Am J Surg 157: 501-502, 1989
56. Silverstein MJ, Gamagami P, Rosser RJ, Gierson ED, Colburn WJ, Handel N, Fingerhut AG, Lewinsky BS, Hoffman RS, Waisman JR: Hooked-wire-directed breast biopsy and overpenetrated mammography. Cancer 59: 715-722, 1987
57. Halverson KJ, Taylor ME, Perez CA, Garcia DM, Myerson R, Philpott G, Levy J, Simpson JR, Tucker G, Rush C: Management of the axilla in patients with breast cancers one centimeter or smaller. Am J Clin Oncol 17: 461-466, 1994
58. Silverstein MJ, Gierson ED, Waisman JR, Colburn WJ, Gamagami P: Predicting axillary node positively in patients with invasive carcinoma of the breast by using a combination of T category and palpability. J Am Coll Surg 180: 700-704, 1995
59. Silverstein MJ, Gierson ED, Waisman JR, Senofsky GM, Colburn WJ, Gamagami P: Axillary lymph node dissection for T1a breast carcinoma. Cancer 73: 664-667, 1994
60. Cady B, Stone MD, Wayne J: New therapeutic possibilities in primary invasive breast cancer. Ann Surg 218: 338-349, 1993
61. Noguchi M, Miyazaki I: Prognostic factors in breast cancer and their controversies (Review). Oncol Rep 1: 1157-1163, 1994
62. Noguchi M, Ohta N, Koyasaki N, Taniya T, Miyazaki I, Mizukami Y: Reappraisal of internal mammary node metastases as a prognostic factor in patients with breast cancer. Cancer 68: 1918-1925, 1991
63. Noguchi M, Koyasaki N, Ohta N, Kitagawa H, Earashi M, Thomas M, Miyazaki I, Mizukami Y: C-erbB-2 oncoprotein expression versus internal mammary lymph node metastases as additional prognostic factors in patients with axillary lymph node-positive breast cancer. Cancer 69: 2953-2960, 1992
64. Noguchi M, Mizukami Y, Kinoshita K, Earashi M, Thomas M, Miyazaki I: Immunohistochemical study of epidermal growth factor and epidermal growth factor receptor in breast carcinoma. Oncol Rep 1: 381-385, 1994
65. Noguchi M, Kitagawa H, Kinoshita K, Thomas M, Miyazaki I, Saito Y, Mizukami Y, Nonomura A, Michigishi T, Nakamura S: The relationship of p53 protein and lymph node metastases in invasive breast cancer. Jpn J Surg 24: 512-517, 1994
66. Leathem A, Dokal I, Atkins N: Carbohydrate expression in breast cancer as an early indicator of metastatic potential. J Path 142: A32, 1984
67. Leathem A, Atkins N, Eisen T: Breast cancer metastasis, survival and carbohydrate expression associated with lectin binding. J Path 145: 73A, 1985
68. Leathem AJ, Brooks SA: Predictive value of lectin binding on breast-cancer recurrence and survival. Lancet i: 1054-1056, 1987
69. Brooks SA, Leathem AJC: Prediction of lymph node involvement in breast cancer by detection of altered glycosylation in the primary tumour. Lancet 339: 71-74, 1991
70. Fenlon S, Bell EJ, Elston CW, Blamey RW: Helix pomatia and Ulex europeus lectin binding in human breast carcinoma. J Pathol 152: 164-176, 1987
71. Alam SM, Whitford P, Cushley W, George WD, Campbell A: Flow cytometric analysis of cell surface carbohydrates in metastatic human breast cancer. Br J Cancer 62: 238-242, 1990
72. Steeg PS, Bevilacqua G, Kopper L, Thorgeirsson UP, Talmadge JB, Liotta LA, Sobel ME: Evidence for a novel gene associated with low tumor metastatic potential. J Natl Cancer Inst 80: 200-204, 1988
73. Hennessy C, Henry JA, May FEB, Westley BR, Angus B, Lennard TWJ: Expression of the antimetastatic gene nm23 in human breast cancer: An association with good prognosis. J Natl Cancer Inst 83: 281-285, 1991
74. Noguchi M, Earashi M, Ohnishi I, Kinoshita K, Thomas M, Fushida S, Miyazaki I, Mizukami Y: nm23 expression versus Helix pomatia lectin binding in human breast cancer metastases. Int J Oncol 4: 1353-1358, 1994
75. Lundy J, Grimson R, Mishriki Y, Chao S, Oravez S, Fromowitz F, Viola MV: Elevated ras oncogene expression correlates with lymph node metastases in breast cancer patients. J Clin Oncol 4: 1321-1325, 1986
76. Oka H, Shiozaki H, Kobayashi K, Inoue M, Tahara H, Kobayashi T, Takatsuka Y, Matsuyoshi N, Hirano S, Takeichi M, Mori T: Expression of E-cadherin cell adhesion molecules in human breast cancer tissues and its relationship to metastases. Cancer Res 53: 1696-1701, 1993
77. Gui GPH, Wells CA, Browne PD, Yeomans P, Jordan S, Puddefoot JR, Vinson GP, Carpenter R: Integrin expression in primary breast cancer and its relation to axillary nodal status. Surgery 117: 102-108, 1995
78. Hadjiminas DJ, Burke M: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Brit J Surg 81: 1615-1616, 1994
79. Davies GC, Millis RR, Hayward JL: Assessment of axillary lymph node status. Ann Surg 192: 148-151, 1980
80. Adami HO, Graffman S, Johansson H, Rimsten A: Survival and recurrences five years after selective treatment for breast carcinoma. Br J Cancer 38: 624-630, 1978
81. Fisher CJ, Boyle S, Burke M, Price AB: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Br J Surg 80: 457-458, 1993
82. Kissin MW, Price AP, Thompson EM, Slavin G, Kark AE: The inadequacy of axillary sampling in breast cancer. Lancet i: 1219-1212, 1982
83. Steele RJC, Forrest APM, Gibson T, Stewart HJ, Chetty U: The efficacy of lower axillary sampling in obtaining lymph node status in breast cancer: a controlled randomized trial. Br J Surg 72: 368-369, 1985
84. Forrest AP, Stewart HJ, Roberts MM, Steele MB: Simple mastectomy and axillary node sampling (pectoral node biopsy) in the management of primary breast cancer. Ann Surg 196: 371-378, 982
85. Graversen HP, Blichert-Toft M, Andersen JA, Zedeler K: Breast cancer: risk of axillary recurrence in node-negative patients following partial axillary dissection of the axilla. Eur J Surg Oncol 14: 407-412, 1988
86. Noguchi M: Comment: Intraoperative assessment of nodal status in the selection of patients with breast cancer for axillary clearance. Brit J Sug 82: 714-715, 1995
87. Guiliano AE, Kirgan DM, Guenther JM, Morton DL: Lymphatic mapping and sentinel lymphadenopathy for breast cancer. Ann Surg 220: 391-401, 1994
88. Guiliano AE, Dale PS, Turner RR, Morton DL, Evans SW, Krasne DL: Improved axillary staging of breast cancer with sentinel lymphadenectomy. Ann Surg 222: 394-401, 1995
89. International (Ludwig) Breast Cancer Study Group: Prognostic importance of occult axillary lymph node micrometastases from breast cancer. Lancet 335: 1565-1568, 1990
90. Pickren JW: The significance of occult metastases; A study of breast cancer. Cancer 14: 1266-1271, 1961
91. Wilkinson EJ, Hause LL, Hoffman RG et al.: Occult axillary lymph node metastases in invasive breast carcinoma: Characteristics of the primary tumor and significance of the metastases. Pathol Annu 17 (pt2): 67-91, 1982
92. Trojani M, de Mascarel I, Bonichon F, Coindre JM, Delsol G: Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. Br J Cancer 55: 303-306, 1987
93. Schoenfeld A, Luqmani Y, Smith D, O'Reilly S, Shousha S, Sinnett HD, Coombes RC: Detection of breast cancer micrometastases in axillary lymph nodes by using polymerase chain reaction. Cancer Res 54: 2986-2990, 1994
94. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaola S, Koyama H: The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase - polymerase chain reaction. Cancer 74: 1595-1600, 1994
95. Huvos AG, Hutter RV, Berg JW: Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg 173: 44-46, 1971
96. Rosen PP, Saigo PE, Braun DW, Weathers E, Fracchia AA, Kinne DW: Axillary micro- and macrometastases in breast cancer. Ann Surg 194: 585-591, 1981
97. Davidson T: Why I favour axillary node clearance in the management of breast cancer. Eur J Surg Oncol 21: 5-7, 1995